Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Baidu Ventures portfolio company Qitan Technology has pulled in $14.1m to progress its pathogen detection technology for drug development and diagnostics.

Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

6 Dimensions Capital led a round for mental health treatment portal Haoxinqing that will go to expanding the latter's R&D and partnership activities.

Biopharmaceutical firm Jubilant Life Sciences has licensed molecules with potential to fight cancer to a new venture formed with Frazier Healthcare Partners.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Medical data aggregation tool developer Owkin increased its series A round to $52m after an extension backed by existing investors GV, Eight Road Ventures and F-Prime Capital.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

China Life Insurance has led a $78m series C round for Vazyme Biotech following the regulatory approval of its Covid-19 detection kit.